Protagonist Therapeutics Inc
NASDAQ:PTGX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Protagonist Therapeutics Inc
NASDAQ:PTGX
|
US |
|
Shanghai Jinjiang Shipping Group Co Ltd
SSE:601083
|
CN |
|
China Resources Beer Holdings Co Ltd
HKEX:291
|
HK |
|
L
|
Life Science REIT PLC
LSE:LABS
|
UK |
|
Elm Company SJSC
SAU:7203
|
SA |
|
Hanover Insurance Group Inc
NYSE:THG
|
US |
|
Cohu Inc
NASDAQ:COHU
|
US |
|
CLARIVATE PLC
NYSE:CLVT
|
UK |
|
Baozun Inc
NASDAQ:BZUN
|
CN |
|
Duke Energy Corp
NYSE:DUK
|
US |
|
Fabrinet
NYSE:FN
|
KY |
|
A
|
Active Biotech AB publ
STO:ACTI
|
SE |
|
CK Asset Holdings Ltd
HKEX:1113
|
HK |
|
Anheuser Busch Inbev SA
XETRA:1NBA
|
BE |
Bankruptcy Probability
Protagonist Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Protagonist Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Protagonist Therapeutics Inc
NASDAQ:PTGX
|
6.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
380.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
181.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
66.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
44.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Protagonist Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Protagonist Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.
